ACT -Groups for Parents to Children With Disabilities (NavigatorACT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03830476|
Recruitment Status : Recruiting
First Posted : February 5, 2019
Last Update Posted : February 5, 2019
|Condition or disease||Intervention/treatment||Phase|
|Parenting Stress Disability, Developmental Behavior, Child Acceptance Processes Parent-Child Relations||Behavioral: Acceptance- and Commitment therapy group for parents to children with disabilities Behavioral: Treatment as usual.||Not Applicable|
Navigator ACT group treatment consists of 5 sessions (each 3.5 hours), and is developed to address distress in parents raising a child with an Autism Spectrum Disorder and/or other disabilities.The aims of the study is to examine the feasibility, participant satisfaction and efficacy of the manual-based Navigator ACT group treatment in (a) improving psychological/behavioral flexibility (b) increasing mindfulness (c) reducing symptoms of depression and anxiety (d) reducing parenting stress (e) reducing behavioral problems of children with disability. This pragmatic multicenter RCT will be conducted mainly in Stockholm County Council disability services but even in other regions in Sweden. Parents participating in the study have their children (0-17 years) currently enrolled in the disability services (experiment group n=42, control group n=42, totaling at least 84 parents, with the power calculation for medium large effect of 90% ES=0.50). To balance for attrition approximately 100 parents will be included in the study.
The participants will be block randomized in several blocks. The experiment group will be receiving Navigator ACT treatment directly after the randomizing procedure, the control group approximately six months after. The parents in the control group fill the efficacy-related self-rating forms at the same measuring points as the parents in the experiment group as well during their own group process.
The feasibility of Navigator ACT in the disability services context is measured by attendance, that is: parents participating in at least 4 out of 5 sessions are considered as completers. The parent satisfaction is measured by session- and course evaluations. Five self-rating questionnaire are used to measure efficacy: The Mindfulness Awareness Attention Scale (MAAS), Parental Acceptance and Action Questionnaire (PAAQ) Parental Stress Scale (PSS) Hospital Anxiety and depression scale (HADS), The Strengths and Difficulties Questionnaire (SDQ). Self-rating questionnaires are administered to parents at the baseline (0-2 weeks before the treatment start, T1), at the end of the treatment (0-2 weeks after, T2) and at the follow-up (3-4 months after the end of the treatment, T3). The data will be analyzed from baseline T1 to T2 (post treatment) as well as from T1 (baseline) to T3 (follow-up) with separate series of repeated measures ANOVA between-group.
The Regional Ethics Committee of Stockholm (2016/526-21-1,2016/115-31/4, 2017/573-31/5 ) has approved the study.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||RCT|
|Masking:||Double (Participant, Care Provider)|
|Masking Description:||Masking at baseline of both participant and care-provider.|
|Official Title:||Acceptance and Commitment Therapy Group, Navigator ACT for Parents to Children With Disabilities|
|Actual Study Start Date :||January 2, 2018|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||December 31, 2020|
Experimental: Acceptance- and Commitment therapy group
Experiment group that receives the treatment direct after the baseline measurement.
Behavioral: Acceptance- and Commitment therapy group for parents to children with disabilities
ACT groups adjusted for parents to children with (any kind of) disabilities.
Other Name: Navigator ACT group treatment
Active Comparator: Treatment as usual
Comparison group that receives treatment as usual and the Navigator ACT intervention appr 6 months later.
Behavioral: Treatment as usual.
Treatment as usual within outpatient disability services.
- 1. Change (increase) in parental psychological flexibility [ Time Frame: [Time Frame: Change in psychological flexibility measured at baseline, immediately after the intervention and at three-four month follow-up] ]Parental Acceptance and Action Questionnaire (PAAQ), a 15-item scale that targets psychological flexibility in the parenting context, i.e. measures to which extent parents' accept inner and outer experiences as they are and are willing to take action in parenting situations
- 2. Change (increase) in mindfulness skills [ Time Frame: [Time Frame: Change in psychological flexibility measured at baseline, immediately after the intervention and at three-four month follow-up] ]The Mindfulness Awareness Attention Scale (MAAS), a 15-item scale (scored 1-6) assessing dispositional mindfulness in regards to cognitive, emotional, physical, interpersonal and general domains.
- 3. Change (decrease) in depression and anxiety [ Time Frame: [Time Frame: Change in psychological flexibility measured at baseline, immediately after the intervention and at three-four month follow-up] ]Hospital Anxiety and Depression Scale (HADS). Has 14 items scored 0 ("Often") - 3 ("Seldom"), subsequently summarized for an overall score; high scores indicate higher levels of depression or anxiety.
- 4. Change (decrease) in parental stress. [ Time Frame: [Time Frame: Change in psychological flexibility measured at baseline, immediately after the intervention and at three-four month follow-up] ]The Parental Stress Scale (PSS) is a18-item tool for measurement of parenting stress, scored 1-5 on a 5-point Likert scale. The initial factor has suggested four-factor structure for the PSS consisting of parental 1) rewards, 2) stressors, 3) lack of control and 4) satisfaction in parenting. High scores indicate higher levels of stress in parenting context.
- 5. Change (decrease) in child's difficulties and the impact of these difficulties on the child's family. [ Time Frame: [Time Frame: Change in psychological flexibility measured at baseline, immediately after the intervention and at three-four month follow-up] ]The Strengths and Difficulties Questionnaire (P4-17 SDQ), a caregiver administered, 25-item extended version of SDQ used for behavior screening of children and adolescents in ages 4-17 years. The SDQ P4-17 covers common areas of emotional and behavioral difficulties and strengths as well as includes a caregiver reported impact- and burden assessment.
- Treatment Credibility Scale (TCS) [ Time Frame: Time Frame: Measured at baseline, immediately after the intervention and at three month follow-up] ]As a measure of feasibility, TCS is used to measure the expectation of improvement and treatment credibility. The TCS is a visual analogue scale rated from "Low credibility"/ "Not at all" (0) to "High credibility"/"Very much" (10) and the score calculated is a mean of all items. The TCS was administered after providing thorough information and presentation of the treatment content at baseline and after completion of the treatment. The item wording after adjustment to the current study were: (1) How logical does Navigator ACT treatment seem to you? (2) How confident are you that this treatment will reduce your distress? (3) Would you recommend Navigator ACT to a friend experiencing the same type of distress? (4) How successful do you feel this type of intervention is in improving your psychological health? 5) At this very moment, to what degree the intervention has improved your psychological health?
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03830476
|Contact: Tatja Hirvikoski, Associate firstname.lastname@example.org|
|Contact: Tiina Holmberg Bergman, M.Sc.||+email@example.com|
|Stockholm, Sweden, 17177|
|Contact: Tiina Holmberg Bergman 705755788 firstname.lastname@example.org|
|Principal Investigator: Tatja Hirvikoski, Docent|